167 related articles for article (PubMed ID: 31904442)
1. Opioid receptors mRNAs expression and opioids agonist-dependent G-protein activation in the rat brain following neuropathy.
Llorca-Torralba M; Pilar-Cuéllar F; da Silva Borges G; Mico JA; Berrocoso E
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109857. PubMed ID: 31904442
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.
Rojewska E; Wawrzczak-Bargiela A; Szucs E; Benyhe S; Starnowska J; Mika J; Przewlocki R; Przewlocka B
Neuroscience; 2018 Oct; 390():293-302. PubMed ID: 30176322
[TBL] [Abstract][Full Text] [Related]
3. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
[TBL] [Abstract][Full Text] [Related]
4. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
Schroeder JA; Niculescu M; Unterwald EM
Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
[TBL] [Abstract][Full Text] [Related]
5. In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.
Kuo A; Magiera J; Rethwan N; Andersson Å; Leen Lam A; Wyse B; Meutermans W; Lewis R; Smith M
Eur J Pharmacol; 2020 Apr; 872():172947. PubMed ID: 31991138
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia.
Rutten K; Tzschentke TM; Koch T; Schiene K; Christoph T
Eur J Pharmacol; 2014 Oct; 741():264-71. PubMed ID: 25169429
[TBL] [Abstract][Full Text] [Related]
7. Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.
Machelska H; Celik MÖ
Front Immunol; 2020; 11():300. PubMed ID: 32194554
[TBL] [Abstract][Full Text] [Related]
8. GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain.
Viguier F; Michot B; Kayser V; Bernard JF; Vela JM; Hamon M; Bourgoin S
Neuropharmacology; 2012 Nov; 63(6):1093-106. PubMed ID: 22820553
[TBL] [Abstract][Full Text] [Related]
9. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin/KOP and nociceptin/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens.
Caputi FF; Di Benedetto M; Carretta D; Bastias del Carmen Candia S; D'Addario C; Cavina C; Candeletti S; Romualdi P
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():36-46. PubMed ID: 24184686
[TBL] [Abstract][Full Text] [Related]
11. CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats.
Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
Pharmacol Rep; 2023 Jun; 75(3):634-646. PubMed ID: 36637684
[TBL] [Abstract][Full Text] [Related]
12. The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.
Atigari DV; Paton KF; Uprety R; Váradi A; Alder AF; Scouller B; Miller JH; Majumdar S; Kivell BM
Neuropharmacology; 2021 Mar; 185():108445. PubMed ID: 33383089
[TBL] [Abstract][Full Text] [Related]
13. Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.
Llorca-Torralba M; Pilar-Cuéllar F; Bravo L; Bruzos-Cidon C; Torrecilla M; Mico JA; Ugedo L; Garro-Martínez E; Berrocoso E
Mol Neurobiol; 2019 Jun; 56(6):4135-4150. PubMed ID: 30284123
[TBL] [Abstract][Full Text] [Related]
14. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
15. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
Sim-Selley LJ; Daunais JB; Porrino LJ; Childers SR
Neuroscience; 1999; 94(2):651-62. PubMed ID: 10579225
[TBL] [Abstract][Full Text] [Related]
16. Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain.
Labuz D; Machelska H
J Pharmacol Exp Ther; 2013 Sep; 346(3):535-44. PubMed ID: 23820126
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of combined morphine and MK-801 administration to the locus coeruleus of a rat neuropathic pain model.
Llorca-Torralba M; Mico JA; Berrocoso E
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):257-266. PubMed ID: 29524514
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Selley DE; Dworkin SI; Childers SR
J Neurosci; 1996 Apr; 16(8):2684-92. PubMed ID: 8786444
[TBL] [Abstract][Full Text] [Related]
20. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
